Trial Profile
A prospective, observational, multicenter study of levodopa/carbidopa infusion gel (LCIG) in patients with advanced Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2016
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms EDIS study
- 27 Sep 2016 New trial record